Literature DB >> 15486368

Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia.

Jose M Querol-Ribelles1, Jose M Tenias, Enric Grau, Jose M Querol-Borras, Jose L Climent, Emilio Gomez, Isidoro Martinez.   

Abstract

STUDY
OBJECTIVES: The aim of this study was to investigate the prognostic value of plasma d-dimer levels in patients with community-acquired pneumonia (CAP).
DESIGN: Prospective observational study.
SETTING: Hospital Lluis Alcanyis of Xativa, Spain. PATIENTS: Consecutive adult patients admitted to the hospital with CAP from January 2000 to October 2002. MEASUREMENTS AND
RESULTS: A total of 302 patients were included. Plasma d-dimer was measured using an automated latex assay. The relationships between plasma d-dimer and prognostic variables included in the pneumonia severity index (PSI) were examined using univariate and multivariate linear and logistic regression analyses. d-Dimer levels were negative (ie, < 500 ng/mL) in 16.9% of the patients. In nonsurvivors, the d-dimer plasma level mean value was 3,786 ng/mL, while in survivors it was 1,609 ng/mL (p < 0.0001). A significant relationship was found between the presence of elevated d-dimer levels and the PSI and APACHE (acute physiology and chronic health evaluation) II score. Elevated d-dimer levels were associated with radiologic pneumonia extension. The d-dimer predictive value for mechanical ventilation therapy showed an area under the curve of 0.78 (95% confidence interval, 0.71 to 0.81).
CONCLUSIONS: d-Dimer plasma levels could be useful for predicting clinical outcome in patients with CAP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486368     DOI: 10.1378/chest.126.4.1087

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  33 in total

1.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 2.  Statins for community-acquired pneumonia: current state of the science.

Authors:  D Viasus; C Garcia-Vidal; F Gudiol; J Carratalà
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-27       Impact factor: 3.267

Review 3.  Cardiovascular implications from untreated human immunodeficiency virus infection.

Authors:  Jason V Baker; Jens D Lundgren
Journal:  Eur Heart J       Date:  2011-01-12       Impact factor: 29.983

Review 4.  Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Authors:  Deirdre Morley; Antoni Torres; Catia Cillóniz; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

5.  Procalcitonin and pneumonia: is it a useful marker?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

6.  The association between plasma D-dimer levels and community-acquired pneumonia.

Authors:  Sulhattin Arslan; Serdal Ugurlu; Gokten Bulut; Ibrahim Akkurt
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 7.  Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.

Authors:  Mirjam Christ-Crain; Steven M Opal
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

8.  Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway.

Authors:  Jakub Kwiecinski; Sara Rhost; Linda Löfbom; Maria Blomqvist; Jan Eric Månsson; Susanna L Cardell; Tao Jin
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

9.  Prevalence and significance of coagulation abnormalities in community-acquired pneumonia.

Authors:  Eric B Milbrandt; Michael C Reade; MinJae Lee; Stephanie L Shook; Derek C Angus; Lan Kong; Melinda Carter; Donald M Yealy; John A Kellum
Journal:  Mol Med       Date:  2009-09-08       Impact factor: 6.354

Review 10.  The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy.

Authors:  Jean-Paul Mira; Adeline Max; Pierre-Regis Burgel
Journal:  Crit Care       Date:  2008-11-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.